glp 1 side effects cancer Glucagon-like peptide-1 medicines and Does GLP-1 Cause Colon Cancer?

[DOI] [PubMed] [Google Scholar] 78.Schrijvers E

DAPA-HF (Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure) revealed that the use of dapagliflozin in patients with New York Heart Association (NYHA) class II, III, or IV heart failure and an ejection fraction of 40% resulted in a lower risk of worsening heart failure and cardiovascular death

The current price, which is partially a function of supply / demand, is putting pressure even on institutions abilities to keep the drugs stocked

Kidney outcomes with glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter 2 inhibitors, dipeptidyl peptidase-4 inhibitors, and sulfonylureas in type 2 diabetes and moderate cardiovascular risk

Appetite changes typically appear within two to four weeks

Results A total of 44 373 patients with IIH were identified